26/05/2021 – Royal Berks to close its hydrotherapy pool
An earlier decision by local NHS funders had made it ‘untenable’ to keep the pool open, says the hospital’s chief executive Steve McManus (pictured below)
The Royal Berkshire Hospital has announced it will be closing its hydrotherapy pool because it is ‘no longer financially viable’.
The move comes after a decision late last year by Berkshire West Clinical Commissioning Group to stop routine NHS funding of the hydrotherapy service. Community groups or charities that have privately rented the pool for the benefit of vulnerable people will now also have to find another venue.
‘We recognise our decision to close the pool will be unwelcome news for a number of groups who use this facility and I am writing to them separately today offering them the opportunity to meet with us to talk through our decision,’ said Steve McManus, chief executive of Royal Berkshire NHS Foundation Trust, in a letter to stakeholders on 21 May 2021. ‘However, we need to align our services to those being commissioned, and the CCG’s decision makes the continued operation of the hydrotherapy suite untenable,’ he added.
The trust will now begin a four-week public engagement process and take feedback to its board of directors in July 2021. Details of the hospital’s position can be found on page 99 of agenda papers for its 26 May 2021 board of directors meeting in public.
25/05/2021 – New Chief Nursing Officer Appointed at Royal Berkshire Hospital
Eamonn Sullivan, who was previously Chief Nurse at The Royal Marsden NHS Foundation Trust, has been appointed Chief Nursing Officer at the Royal Berkshire NHS Foundation
Trust (RBFT). He replaces Caroline Ainslie who retired last week after nine years at the Trust. He joins the Trust as it continues with its ambitious programme of renewal, recovery and redevelopment of the Royal Berkshire Hospital site in Reading.
Click here or the image above to read more
29/03/2021 – Pioneering radiotherapy technology launched at Berkshire Cancer Centre, based at Royal Berkshire NHS Foundation Trust
Pioneering radiotherapy technology, which will revolutionise the way some cancer patients are treated, is being launched at the Berkshire Cancer Centre (BCC), based at Reading’s Royal Berkshire NHS Foundation Trust (RBFT) this week.
Studies have shown that SABR – Stereotactic Ablative Body Radiotherapy – can be more effective than traditional radiotherapy for some cancers because it delivers a far more powerful, targeted beam of high energy X-rays directly to a tumour.
This means the tumour receives a very large dose in fewer treatments and fewer visits to the department for patients.
SABR’s higher precision means the very intensive beams are targeted exactly on the tumour. Initially it will be used to treat lung cancer patients but the plan is to then roll it out to treat other appropriate cancers for which benefit has been proven.
Read the full press release by clicking here or on the image above.